Phase ON

Our Team

Executive Board

Dr. Ambar Vaidya

Founder President & Chief Executive Officer

As a founder member, overall responsibility for Global Operations within PhaseON

More than 30 years experience in Pharmaceutical Industry with over 27+ years in Clinical Research having done doctorate in Clinical Research and Masters in Business Development

  • Instrumental in establishing operations for first largest global CRO in India. Worked with leading CROs like Quintiles, Lambda, Encorium Research (earlier Progenitor) and Accutest in the past.
  • Worked previously as a member of the board for global CROs in India and Hong Kong. Worked extensively in global leadership position with the teams in India, Latin America and in CEE region in the capacity as Project Director for several Global-Multi Country studies in the past.
  • Key therapeutic experience: Infectious Diseases & Vaccines, Psychiatry, Oncology, Hematology, Respiratory, Dermatology, Gastroenterology, CNS, Pediatrics, Pain Management, innovation Medical Devices, Neutraceuticals/Ayurvedic (AYUSH) products and several OTC studies.
  • Associated as an honorary faculty and mentor to few of the reputed clinical research and management institutes in Ahmedabad, Vadodara and Mumbai

Director Europe

Klaus-Dieter Albrecht RPh

Based out of Münster, Germany

35+ years of experience in Clinical Research and other leadership positions in Global Pharma and CRO Industry

  • Coordinates the Project Management team in India as well as Business Development.
  • Previously worked with reputed Global Companies like Wyeth (Germany & Switzerland), Force GmbH, Sangupharm GmbH, Schwarz Pharma AG (Germany & USA). Was founder President and Director with Progenitor International Research, Encorium Research and Novartis AG (Switzerland) – Currently on Board of PhaseON Clinical Research India / Europe.
  • Excellent contacts within Regulatory authorities, particularly EU Region.
  • Established relationships with key investigator sites and key opinion leaders.
  • Key therapeutic experience: Infectious Diseases & Vaccines, Oncology, Hematology, Respiratory, CNS, CVS, Pain, Diabetes, Dermatology, Medical Devices.

Advisory Board

Dr. Bhaswat S. Chakraborty

Former Senior Reviewer – Safety & Efficacy Review – CANADIAN FDA

Dr. Bhaswat S. Chakraborty is a PhD in Clinical Pharmacology from University of Saskatchewan, Saskatoon, Canada and is associated with PhaseON Clinical Research in the capacity of honorary advisor for scientific affairs

  • Dr. Chakraborty worked at the Health Protection Branch, Ministry of Health, Government of Canada (Canadian FDA) in Ottawa and served as a Senior Clinical Reviewer and Acting Department Head of the New Drug Applications. In this role, he has evaluated more than 300 Abbreviated New Drug Applications and 20 Pharmacokinetics based New Drug Applications.
  • He was the Director of Biopharmaceutics at Biovail Corporation International, Toronto. Till date, he has designed and investigated ~600 Phase I and 60 higher Phase Clinical Studies for the FDA, TPP, EU and other Agencies.
  • Recipient of many prestigious research grants, Dr. Chakraborty is also an author and co-author of more than 100 scientific papers and abstracts in refereed international journals.
  • He is an Honorary Professor and External Examiner to a few universities; editorial board member of three international journals; reviewer of many professional journal manuscripts, and also on the board of several Institutes and Universities in India and USA in various capacities.